US Stock MarketDetailed Quotes

Health Catalyst (HCAT)

Watchlist
  • 1.950
  • +0.230+13.37%
Close Mar 4 16:00 ET
  • 1.960
  • +0.010+0.51%
Post 17:03 ET
137.93MMarket Cap-1.23P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Health Catalyst (HCAT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-0.04%76.32M
6.35%80.72M
6.28%79.41M
3.60%306.58M
6.02%79.61M
3.50%76.35M
3.67%75.9M
1.16%74.72M
7.13%295.94M
8.56%75.08M
Operating revenue
-0.04%76.32M
6.35%80.72M
6.28%79.41M
3.60%306.58M
6.02%79.61M
3.50%76.35M
3.67%75.9M
1.16%74.72M
7.13%295.94M
8.56%75.08M
Cost of revenue
-8.99%38.51M
6.04%42.48M
12.10%43.18M
1.04%165.81M
0.76%44.92M
1.26%42.31M
1.58%40.06M
0.56%38.52M
14.72%164.11M
16.98%44.58M
Gross profit
11.09%37.82M
6.69%38.24M
0.08%36.24M
6.79%140.78M
13.71%34.69M
6.42%34.04M
6.12%35.84M
1.81%36.21M
-1.02%131.83M
-1.76%30.51M
Operating expense
15.92%55.33M
-9.84%46.57M
-4.43%56.41M
-18.61%210.59M
-17.54%52.19M
-15.63%47.73M
-24.48%51.65M
-16.26%59.02M
-5.29%258.73M
-6.65%63.29M
Selling and administrative expenses
29.21%30.43M
-20.72%21.49M
-14.04%28.9M
-22.71%111.2M
-17.67%26.92M
-17.97%23.55M
-32.35%27.11M
-20.71%33.62M
-3.58%143.88M
-10.46%32.7M
-Selling and marketing expense
26.62%14.36M
3.62%13.21M
-22.67%14.74M
-19.21%54.39M
-34.91%11.24M
-24.81%11.34M
-22.27%12.75M
2.63%19.06M
-23.07%67.32M
-15.23%17.27M
-General and administrative expense
31.62%16.07M
-42.32%8.28M
-2.76%14.16M
-25.79%56.82M
1.63%15.68M
-10.39%12.21M
-39.32%14.36M
-38.89%14.56M
24.08%76.56M
-4.46%15.43M
Research and development costs
-13.47%12.28M
-10.75%12.39M
2.12%15.19M
-20.21%57.95M
-26.05%15M
-19.66%14.19M
-21.07%13.88M
-12.94%14.87M
-4.03%72.63M
3.44%20.29M
Depreciation amortization depletion
26.35%12.61M
19.02%12.68M
17.05%12.32M
-1.88%41.43M
-0.37%10.27M
-2.03%9.98M
-0.73%10.66M
-4.27%10.53M
-12.58%42.22M
-11.66%10.3M
-Depreciation and amortization
26.35%12.61M
19.02%12.68M
17.05%12.32M
-1.88%41.43M
-0.37%10.27M
-2.03%9.98M
-0.73%10.66M
-4.27%10.53M
-12.58%42.22M
-11.66%10.3M
Operating profit
-27.92%-17.51M
47.33%-8.33M
11.58%-20.17M
44.99%-69.81M
46.62%-17.5M
44.32%-13.69M
54.34%-15.81M
34.66%-22.81M
9.36%-126.9M
10.78%-32.79M
Net non-operating interest income expense
-223.44%-4.5M
-273.66%-4.13M
-247.67%-3.49M
-90.16%896K
-194.41%-2.45M
-152.79%-1.39M
14.06%2.38M
31.99%2.36M
642.43%9.1M
181.76%2.6M
Non-operating interest income
-76.01%1.14M
-60.60%1.66M
-8.55%3.83M
9.72%17.98M
9.64%4.85M
6.21%4.74M
7.84%4.21M
16.20%4.19M
--16.39M
--4.42M
Non-operating interest expense
-8.02%5.64M
215.54%5.79M
300.00%7.32M
134.47%17.09M
299.62%7.3M
236.04%6.13M
0.71%1.83M
0.66%1.83M
--7.29M
--1.83M
Other net income (expense)
-46.34%-180K
-177,675.00%-28.44M
686.36%129K
-6,575.00%-259K
-566.67%-98K
-339.29%-123K
-366.67%-16K
-540.00%-22K
4K
21K
Special income (charges)
--0
---28.77M
----
----
----
--0
--0
----
----
----
-Less:Impairment of capital assets
--0
--28.77M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
-46.34%-180K
2,131.25%325K
686.36%129K
-6,575.00%-259K
-566.67%-98K
-339.29%-123K
-366.67%-16K
-540.00%-22K
--4K
--21K
Income before tax
-45.96%-22.19M
-204.16%-40.9M
-14.91%-23.53M
41.28%-69.17M
33.55%-20.05M
30.82%-15.2M
58.66%-13.45M
38.18%-20.47M
16.86%-117.79M
15.55%-30.17M
Income tax
108.63%41K
15.71%81K
90.27%215K
-6.46%333K
337.06%625K
-905.08%-475K
-17.65%70K
63.77%113K
108.32%356K
142.37%143K
Net income
-50.95%-22.23M
-203.18%-40.98M
-15.33%-23.74M
41.17%-69.5M
31.80%-20.67M
33.16%-14.73M
58.56%-13.52M
37.97%-20.59M
14.01%-118.15M
15.29%-30.31M
Net income continuous Operations
-50.95%-22.23M
-203.18%-40.98M
-15.33%-23.74M
41.17%-69.5M
31.80%-20.67M
33.16%-14.73M
58.56%-13.52M
37.97%-20.59M
14.01%-118.15M
15.29%-30.31M
Minority interest income
Net income attributable to the parent company
-50.95%-22.23M
-203.18%-40.98M
-15.33%-23.74M
41.17%-69.5M
31.80%-20.67M
33.16%-14.73M
58.56%-13.52M
37.97%-20.59M
14.01%-118.15M
15.29%-30.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-50.95%-22.23M
-203.18%-40.98M
-15.33%-23.74M
41.17%-69.5M
31.80%-20.67M
33.16%-14.73M
58.56%-13.52M
37.97%-20.59M
14.01%-118.15M
15.29%-30.31M
Basic earnings per share
-33.33%-0.32
-156.52%-0.59
0.00%-0.35
44.98%-1.15
37.74%-0.33
38.46%-0.24
60.34%-0.23
41.67%-0.35
18.36%-2.09
19.70%-0.53
Diluted earnings per share
-33.33%-0.32
-156.52%-0.59
0.00%-0.35
44.98%-1.15
37.74%-0.33
38.46%-0.24
60.34%-0.23
41.67%-0.35
20.53%-2.09
19.70%-0.53
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -0.04%76.32M6.35%80.72M6.28%79.41M3.60%306.58M6.02%79.61M3.50%76.35M3.67%75.9M1.16%74.72M7.13%295.94M8.56%75.08M
Operating revenue -0.04%76.32M6.35%80.72M6.28%79.41M3.60%306.58M6.02%79.61M3.50%76.35M3.67%75.9M1.16%74.72M7.13%295.94M8.56%75.08M
Cost of revenue -8.99%38.51M6.04%42.48M12.10%43.18M1.04%165.81M0.76%44.92M1.26%42.31M1.58%40.06M0.56%38.52M14.72%164.11M16.98%44.58M
Gross profit 11.09%37.82M6.69%38.24M0.08%36.24M6.79%140.78M13.71%34.69M6.42%34.04M6.12%35.84M1.81%36.21M-1.02%131.83M-1.76%30.51M
Operating expense 15.92%55.33M-9.84%46.57M-4.43%56.41M-18.61%210.59M-17.54%52.19M-15.63%47.73M-24.48%51.65M-16.26%59.02M-5.29%258.73M-6.65%63.29M
Selling and administrative expenses 29.21%30.43M-20.72%21.49M-14.04%28.9M-22.71%111.2M-17.67%26.92M-17.97%23.55M-32.35%27.11M-20.71%33.62M-3.58%143.88M-10.46%32.7M
-Selling and marketing expense 26.62%14.36M3.62%13.21M-22.67%14.74M-19.21%54.39M-34.91%11.24M-24.81%11.34M-22.27%12.75M2.63%19.06M-23.07%67.32M-15.23%17.27M
-General and administrative expense 31.62%16.07M-42.32%8.28M-2.76%14.16M-25.79%56.82M1.63%15.68M-10.39%12.21M-39.32%14.36M-38.89%14.56M24.08%76.56M-4.46%15.43M
Research and development costs -13.47%12.28M-10.75%12.39M2.12%15.19M-20.21%57.95M-26.05%15M-19.66%14.19M-21.07%13.88M-12.94%14.87M-4.03%72.63M3.44%20.29M
Depreciation amortization depletion 26.35%12.61M19.02%12.68M17.05%12.32M-1.88%41.43M-0.37%10.27M-2.03%9.98M-0.73%10.66M-4.27%10.53M-12.58%42.22M-11.66%10.3M
-Depreciation and amortization 26.35%12.61M19.02%12.68M17.05%12.32M-1.88%41.43M-0.37%10.27M-2.03%9.98M-0.73%10.66M-4.27%10.53M-12.58%42.22M-11.66%10.3M
Operating profit -27.92%-17.51M47.33%-8.33M11.58%-20.17M44.99%-69.81M46.62%-17.5M44.32%-13.69M54.34%-15.81M34.66%-22.81M9.36%-126.9M10.78%-32.79M
Net non-operating interest income expense -223.44%-4.5M-273.66%-4.13M-247.67%-3.49M-90.16%896K-194.41%-2.45M-152.79%-1.39M14.06%2.38M31.99%2.36M642.43%9.1M181.76%2.6M
Non-operating interest income -76.01%1.14M-60.60%1.66M-8.55%3.83M9.72%17.98M9.64%4.85M6.21%4.74M7.84%4.21M16.20%4.19M--16.39M--4.42M
Non-operating interest expense -8.02%5.64M215.54%5.79M300.00%7.32M134.47%17.09M299.62%7.3M236.04%6.13M0.71%1.83M0.66%1.83M--7.29M--1.83M
Other net income (expense) -46.34%-180K-177,675.00%-28.44M686.36%129K-6,575.00%-259K-566.67%-98K-339.29%-123K-366.67%-16K-540.00%-22K4K21K
Special income (charges) --0---28.77M--------------0--0------------
-Less:Impairment of capital assets --0--28.77M--------------0--0------------
Other non- operating income (expenses) -46.34%-180K2,131.25%325K686.36%129K-6,575.00%-259K-566.67%-98K-339.29%-123K-366.67%-16K-540.00%-22K--4K--21K
Income before tax -45.96%-22.19M-204.16%-40.9M-14.91%-23.53M41.28%-69.17M33.55%-20.05M30.82%-15.2M58.66%-13.45M38.18%-20.47M16.86%-117.79M15.55%-30.17M
Income tax 108.63%41K15.71%81K90.27%215K-6.46%333K337.06%625K-905.08%-475K-17.65%70K63.77%113K108.32%356K142.37%143K
Net income -50.95%-22.23M-203.18%-40.98M-15.33%-23.74M41.17%-69.5M31.80%-20.67M33.16%-14.73M58.56%-13.52M37.97%-20.59M14.01%-118.15M15.29%-30.31M
Net income continuous Operations -50.95%-22.23M-203.18%-40.98M-15.33%-23.74M41.17%-69.5M31.80%-20.67M33.16%-14.73M58.56%-13.52M37.97%-20.59M14.01%-118.15M15.29%-30.31M
Minority interest income
Net income attributable to the parent company -50.95%-22.23M-203.18%-40.98M-15.33%-23.74M41.17%-69.5M31.80%-20.67M33.16%-14.73M58.56%-13.52M37.97%-20.59M14.01%-118.15M15.29%-30.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -50.95%-22.23M-203.18%-40.98M-15.33%-23.74M41.17%-69.5M31.80%-20.67M33.16%-14.73M58.56%-13.52M37.97%-20.59M14.01%-118.15M15.29%-30.31M
Basic earnings per share -33.33%-0.32-156.52%-0.590.00%-0.3544.98%-1.1537.74%-0.3338.46%-0.2460.34%-0.2341.67%-0.3518.36%-2.0919.70%-0.53
Diluted earnings per share -33.33%-0.32-156.52%-0.590.00%-0.3544.98%-1.1537.74%-0.3338.46%-0.2460.34%-0.2341.67%-0.3520.53%-2.0919.70%-0.53
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.50%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +3.88%
4
Block
XYZ
+3.72%
5
Comcast
CMCSA
+3.48%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +3.22%
Sample Name
Sample Code
 +1.26%
Sample Name
Sample Code
 -0.52%
4
Zai Lab
ZLAB
-0.62%
5
Kanzhun
BZ
-2.28%
View More
Trump cheers on towards 100,000! Will the Dow continue its surge after breaking through 50,000 point
On February 10 Eastern Time, the Dow Jones Industrial Average hit another all-time high! Previously, on February 6, the Dow surpassed the hi Show More
Is the US stock market entering a recovery phase? Trump and Jensen Huang both 'chiming in' with these three key trends worth watching!
Wait for the right moment to act

- No more -